サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1498737

ラジオセラノスティクス市場：放射性同位元素別、アプローチ別、用途別、地域別-産業分析、市場規模、市場シェア、2024～2032年予測

Radiotheranostics Market, By Radioisotope, By Approach, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 284 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.02円
ラジオセラノスティクス市場：放射性同位元素別、アプローチ別、用途別、地域別-産業分析、市場規模、市場シェア、2024～2032年予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ラジオセラノスティクス市場規模は2023年に21億1,520万米ドルと評価され、2024～2032年にかけて14.20%のCAGRで拡大

ラジオセラノスティクス市場-市場力学

がん罹患率の増加が市場成長を促進

がん罹患率の上昇に伴い、ラジオセラノスティクスの市場開拓は今後も続くと予想されます。制御不能に増殖した体細胞が体の他の部分に転移することは、がん状態として知られています。がんに関しては、診断と治療の両方の目的でペアになった放射性核種プローブが、特定の（通常はがん性の）細胞を標的かつ選択的に検出・治療するために使用されます。各プローブは患者の基礎疾患に合わせて調整され、治療結果と効率を向上させる。このように、放射性核種医療は個別化医療を超えます。たとえば、英国のがん研究機関であるCancer Research UKによれば、2020年には1,800万例以上のがんが新たに発見されるといいます。さらに、2040年までに世界中で2,800万人のがん患者が増えると予測されており、これは2020年から54.9％増加し、この増加は女性（48.8％増加）に比べて男性（60.6％増加）に不釣り合いです。その結果、ラジオセラノスティクスの市場は、がんの罹患率の上昇によって牽引されることになります。

ラジオセラノスティクス市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024～2032年）に約14.20％のCAGRで毎年成長すると推定されます。

アプローチ別では、標的治療カテゴリーは2023年に最大の市場シェアを示すと予測されました。

用途別では、2023年には腫瘍カテゴリーが主要タイプに

地域別では、北米が2023年に主要な収益源となりました。

ラジオセラノスティクス市場-セグメンテーション分析：

世界のラジオセラノスティクス市場は、放射性同位元素、アプローチ、用途、地域によって区分されます。

市場は放射性同位元素に基づいて2つのカテゴリーに分けられます：ヨウ素131、ロジン123、ガリウム68、ルテチウム177、18F・Y-90、その他の放射性同位元素です。ルテチウム-177カテゴリーが市場を独占しており、これはLU-177製品の使用量と入手可能性が拡大していることが背景にあります。さらに、Lu-177は他の治療用アイソトープよりも半減期が長いため、治療期間が長くなり、患者の転帰が良くなる可能性があります。例えば、Springer社によれば、L-177の物理的半減期は6.7日です。最近の製品承認や新発売もこのセグメントの成長を加速させています。さらに、Novartisは2022年12月、前立腺がん治療用の標的放射性リガンド療法であるPluvictoの販売承認を欧州委員会から取得しました。

同市場は用途別に以下のカテゴリーに分類される：腫瘍（甲状腺がん、神経内分泌腫瘍、肝細胞がん、前立腺がん、その他の腫瘍用途）と非腫瘍（神経疾患、関節炎、その他の非腫瘍用途）です。がん領域が市場を独占しており、予測期間中もその優位性を維持するとみられます。この高い比率は、がんのラジオセラノスティクスが宇宙で広く利用されているという事実によって説明できます。さらに、新製品の承認、間近に迫った製品の発売、最先端のイメージングツールや治療ソリューションの開発に対するニーズの変化などが、業界の拡大を後押しすると予測されています。Pluvicto、LUTATHERA、AZEDRA、その他のがん関連セラノスティクスはその一例です。医療従事者が核医療を好むようになったことで、がんラジオセラノスティクスの有効性が高まっています。さらに、がん疾患に対する革新的な核医療の研究費の増加が、事業の成長を支えるものと予想されます。

ラジオセラノスティクス市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

予測期間中、北米がラジオセラノスティクスの世界市場で最大のシェアを占めると予想されています。北米の放射性抗がん剤市場は、治療用放射性医薬品の需要、精密医療への動向の高まり、効率的なイメージング技術の利用の増加によって押し上げられています。さらに、このセグメントは多様な産業関係者とその戦略的努力によって牽引されています。例えば、2023年3月、Ratio Therapeutics Inc.は、PETイメージングに使用されるMerckの標的薬のライセンスを取得したと発表しました。

また、アジア太平洋では、予測期間中に放射性抗がん剤市場が世界で最も速い速度で拡大すると予想されています。同地域のがん罹患率の高さと核医療投資の拡大が、同地域市場の成長を後押しする主要要因となっています。例えば、2021年3月、Global Medical Solutions, Ltd.とBWXT Medical Ltd.は、アジア太平洋全体で放射性医薬品と放射性同位元素を製造・提供するために協力すると発表しました。アジア太平洋における核イメージング法の増加も市場導入に寄与しています。

放射性医薬品市場-競合情勢：

Telix Pharmaceuticals Limited.、Novartis AG, IsoTherapeutics Group, LLC、Bayer AG、Progenics Pharmaceuticals, Inc.（Lantheus）など、放射線腫瘍学セグメントの有力企業は、その地位を固め競合を維持するために、いくつかの戦略的施策を実施しています。放射線医療技術を向上させるため、これらの企業は、新規放射性医薬品の創出、イメージング剤の強化、治療の可能性の拡大に集中的に取り組む研究開発（R&D）プロジェクトに多額の資金を提供しています。リソースを入手し、知識を交換し、専門知識を活用するために、学術機関、研究センター、その他の業界参加者と提携を結んでいます。さらに、業界をリードする企業同士の提携により、製品の質の向上、顧客基盤の拡大、新製品の迅速な開発が可能になります。

目次

第1章 ラジオセラノスティクス市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブ概要

  • 市場内訳
  • 競合考察

第3章 ラジオセラノスティクスの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ラジオセラノスティクス産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 ラジオセラノスティクス市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 ラジオセラノスティクス市場情勢

  • ラジオセラノスティクス市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ラジオセラノスティクス市場-放射性同位元素別

  • 概要
    • 放射性同位元素別セグメントシェア分析
    • ヨウ素131
    • ヨウ素123
    • ガリウム68
    • ルテチウム177
    • 18F・Y-90
    • その他

第8章 ラジオセラノスティクス市場-アプローチ別

  • 概要
    • アプローチ別セグメントシェア分析
    • 標的治療
    • 標的診断

第9章 ラジオセラノスティクス市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • 腫瘍
      • 甲状腺がん
      • 神経内分泌腫瘍
      • 肝細胞がん
      • 前立腺がん
      • その他の腫瘍用途
    • 非腫瘍
      • 神経学的障害
      • 関節炎
      • その他の非腫瘍用途

第10章 ラジオセラノスティクス市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-ラジオセラノスティクス業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Telix Pharmaceuticals Limited.
    • Novartis AG
    • IsoTherapeutics Group, LLC
    • Bayer AG
    • Progenics Pharmaceuticals, Inc.（Lantheus）
    • ITM Radiopharma
    • Q BioMed Inc.
    • Life Molecular Imaging
    • RadioMedix
    • Nordic Nanovector ASA
    • その他

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Radiotheranostics Market: Radioisotope Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Radioisotope
  • TABLE Global Radiotheranostics Market, by Radioisotope 2019-2032 (USD Million)
  • TABLE Radiotheranostics Market: Approach Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Approach
  • TABLE Global Radiotheranostics Market, by Approach 2019-2032 (USD Million)
  • TABLE Radiotheranostics Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Radiotheranostics Market, by Application 2019-2032 (USD Million)
  • TABLE Radiotheranostics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Radiotheranostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Application, 2019-2032 (USD Million)
目次
Product Code: ANV2906

REPORT HIGHLIGHT

Radiotheranostics Market size was valued at USD 2,115.2 Million in 2023, expanding at a CAGR of 14.20% from 2024 to 2032.

Radiotheranostics is a new area of medicine that combines the use of radiopharmaceuticals for both therapeutic and diagnostic purposes. It includes the simultaneous diagnosis and treatment of illnesses with the use of radiotracers, which are molecules tagged with radioactive isotopes. It involves using single-photon emission computed tomography (SPECT) or positron emission tomography (PET) imaging to see particular molecular targets or biomarkers within the body. Giving comprehensive details regarding the location and severity of the disease facilitates accurate and customized diagnosis. The therapeutic component entails applying the same radiotracer or a comparable substance to give targeted radiation therapy directly to the site of sickness.

Radiotheranostics Market- Market Dynamics

Growing Cancer Prevalence to Propel Market Growth

It is anticipated that the market for radiotheranostics will continue to develop as cancer incidence rises. Uncontrollably growing body cells that spread to other parts of the body are known as cancerous conditions. When it comes to cancer, radionuclide probes that are paired for both diagnostic and therapeutic purposes are used to detect and treat specific (usually cancerous) cells in a targeted and selective manner. Each probe is tailored to the patient's underlying condition, improving treatment outcomes and efficiency. This is how radionuclide medicine goes beyond personalized medicine. For instance, over 18 million new instances of cancer were discovered in 2020, according to Cancer Research UK, a UK-based cancer research organization. Furthermore, it is projected that by 2040, there will be 28 million additional instances of cancer worldwide, a 54.9% rise from 2020 and that this increase would disproportionately affect men (60.6% increase) compared to women (48.8% increase). Consequently, the market for radiotheranostics is driven by the rising incidence of cancer.

Radiotheranostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.20% over the forecast period (2024-2032)

Based on approach segmentation, the targeted therapeutic category was predicted to show maximum market share in the year 2023

Based on application segmentation, the oncology category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Radiotheranostics Market- Segmentation Analysis:

The Global Radiotheranostics Market is segmented on the basis of Radioisotope, Approach, Application, and Region.

The market is divided into two categories based on radioisotope: Iodine-131, lodine-123, Gallium-68, Lutetium-177, 18F with Y-90, and Other radioisotopes. The lutetium-177 category dominates the market, which is fueled by the market's growing LU-177 product usage and availability. Furthermore, Lu-177 has a longer half-life than other therapeutic isotopes, allowing for a longer course of treatment and possibly better patient outcomes. For instance, Springer states that L-177 has a 6.7-day physical half-life. Recent product approvals and fresh releases have also accelerated the segment's growth. Moreover, Novartis was granted European Commission approval in December 2022 to market Pluvicto, a targeted radioligand therapy, for the treatment of prostate cancer.

The market is divided into the following categories based on application: Oncology (Thyroid cancer, Neuroendocrine tumors, Hepatocellular carcinoma, Prostate cancer, Other oncology applications) and Non-oncology (Neurological disorders, Arthritis, Other non-oncology applications). The oncology category dominates the market and is likely to maintain its dominance during the forecast period. This high percentage can be explained by the fact that cancer radiotheranostics items are widely available in space. Furthermore, new product approvals, impending product launches, and the changing need for developing cutting-edge imaging tools and treatment solutions are all projected to fuel industry expansion. Pluvicto, LUTATHERA, AZEDRA, and other cancer-related theranostics are a few examples. The effectiveness of cancer radiotheranostic drugs has increased due to healthcare professionals' preference for nuclear medicine. Furthermore, it is anticipated that rising research expenditures in innovative nuclear medicine for cancer disorders will support business growth.

Radiotheranostics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for radiotheranostics. The market for radiotheranostics in North America is being pushed by the demand for therapeutic radiopharmaceuticals, a growing trend towards precision medicine, and the increased usage of efficient imaging technologies. Moreover, the sector in the area is being driven by a multiplicity of industrial actors and their different strategic endeavours. For example, in March 2023, Ratio Therapeutics Inc. announced that it has licenced a Merck targeted medication used in PET imaging.

In addition, the radiotheranostics market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The high cancer prevalence in the area and growing nuclear medicine investments are the main factors propelling the growth of the regional market. For instance, in March 2021, Global Medical Solutions, Ltd. and BWXT Medical Ltd. announced that they will be working together to produce and provide radiopharmaceuticals and radioisotopes across the Asia Pacific region. An increase in nuclear imaging methods in Asia Pacific is also contributing to the market adoption.

Radiotheranostics Market- Competitive Landscape:

Several strategic measures are being implemented by prominent players such as Telix Pharmaceuticals Limited., Novartis AG, IsoTherapeutics Group, LLC, Bayer AG, and Progenics Pharmaceuticals, Inc.( Lantheus), among others in the radiotheranostics sector to fortify their position and maintain their competitiveness. To improve radiotheranostics technologies, they are heavily funding research and development (R&D) projects that concentrate on creating novel radiopharmaceuticals, enhancing imaging agents, and expanding therapeutic potential. To gain access to resources, exchange knowledge, and capitalize on expertise, they are forming alliances with academic institutions, research centers, and other industry participants. Furthermore, partnerships among industry leaders enable businesses to improve the caliber of their products, broaden their customer base, and expedite the creation of new products.

Recent Developments:

March 2023: Pharma 15 Corporation, a US-based business focused on creating cutting-edge therapeutic radiopharmaceuticals for prostate cancer, has been acquired by Radiopharm Theranostics. Through this calculated move, Radiopharm Theranostics was able to expand its portfolio and solidify its position in the radiotheranostics industry by gaining access to cutting-edge technology and knowledge in the treatment of prostate cancer.

June 2023: Thor Medical, a young manufacturer of alpha-emitters for radiopharmaceuticals intended to cure cancer, was acquired by Nordic Nanovector. By incorporating Thor Medical's knowledge and alpha-emitter technology, this calculated move strengthened Nordic Nanovector's capabilities, diversifying its product line and solidifying its position in the cancer market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RADIOTHERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Telix Pharmaceuticals Limited.

Novartis AG

IsoTherapeutics Group, LLC

Bayer AG

Progenics Pharmaceuticals, Inc.( Lantheus)

ITM Radiopharma

Q BioMed Inc.

Life Molecular Imaging

RadioMedix

Nordic Nanovector ASA

Others

GLOBAL RADIOTHERANOSTICS MARKET, BY RADIOISOTOPE- MARKET ANALYSIS, 2019 - 2032

  • Iodine-131
  • lodine-123
  • Gallium-68
  • Lutetium-177
  • 18F with Y-90
  • Other radioisotopes

GLOBAL RADIOTHERANOSTICS MARKET, BY APPROACH- MARKET ANALYSIS, 2019 - 2032

  • Targeted therapeutic
  • Targeted diagnostic

GLOBAL RADIOTHERANOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Thyroid cancer
  • Neuroendocrine tumors
  • Hepatocellular carcinoma
  • Prostate cancer
  • Other oncology applications
  • Non-oncology
  • Neurological disorders
  • Arthritis
  • Other non-oncology applications

GLOBAL RADIOTHERANOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Radiotheranostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Radiotheranostics Market Snippet by Radioisotope
    • 2.1.2. Radiotheranostics Market Snippet by Approach
    • 2.1.3. Radiotheranostics Market Snippet by Application
    • 2.1.4. Radiotheranostics Market Snippet by Country
    • 2.1.5. Radiotheranostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Radiotheranostics Key Market Trends

  • 3.1. Radiotheranostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Radiotheranostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Radiotheranostics Market Opportunities
  • 3.4. Radiotheranostics Market Future Trends

4. Radiotheranostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Radiotheranostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Radiotheranostics Market Landscape

  • 6.1. Radiotheranostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Radiotheranostics Market - By Radioisotope

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Radioisotope, 2023 & 2032 (%)
    • 7.1.2. Iodine-131
    • 7.1.3. lodine-123
    • 7.1.4. Gallium-68
    • 7.1.5. Lutetium-177
    • 7.1.6. 18F with Y-90
    • 7.1.7. Other radioisotopes

8. Radiotheranostics Market - By Approach

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Approach, 2023 & 2032 (%)
    • 8.1.2. Targeted therapeutic
    • 8.1.3. Targeted diagnostic

9. Radiotheranostics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Oncology
      • 9.1.2.1. Thyroid cancer
      • 9.1.2.2. Neuroendocrine tumors
      • 9.1.2.3. Hepatocellular carcinoma
      • 9.1.2.4. Prostate cancer
      • 9.1.2.5. Other oncology applications
    • 9.1.3. Non-oncology
      • 9.1.3.1. Neurological disorders
      • 9.1.3.2. Arthritis
      • 9.1.3.3. Other non-oncology applications

10. Radiotheranostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Radiotheranostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Radiotheranostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Radiotheranostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Radiotheranostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Radiotheranostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Radiotheranostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Telix Pharmaceuticals Limited.
    • 11.2.2. Novartis AG
    • 11.2.3. IsoTherapeutics Group, LLC
    • 11.2.4. Bayer AG
    • 11.2.5. Progenics Pharmaceuticals, Inc.( Lantheus)
    • 11.2.6. ITM Radiopharma
    • 11.2.7. Q BioMed Inc.
    • 11.2.8. Life Molecular Imaging
    • 11.2.9. RadioMedix
    • 11.2.10. Nordic Nanovector ASA
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us